Investigation & Intelligence Feeds
AECOM’s $390 Million Bet on Artificial Intelligence
Non-tech companies continue efforts to count on AI to transform operations and competitiveness. Infrastructure consulting giant AECOM h...
Indiana & Kentucky Privacy Laws Go Live in the New Year
As businesses prepare for the holiday season and the new year inches closer, now is the time to revisit Indiana and Kentucky’s comprehe...
India’s new privacy law is here: What you need to know
At long last, on November 13, 2025, India’s Ministry of Electronics and Information Technology (MeitY) released the Digital Personal Da...
ToolGen Files Complaint Against Vertex Concerning Gene Therapy Casgevy®
On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement ...
USPTO Puts Subject Matter Eligibility Declarations in the Spotlight
On December 4, 2025, U.S. Patent and Trademark Office (USPTO) Director John Squires issued two memoranda addressing subject matter elig...
The Hidden Risks of Information Disclosure: A Costly Lesson from Cornwall
When Royal Cornwall Hospital responded to a routine Freedom of Information request in 2023, they had no idea they were about to expose ...
Keeping the “human” in human resources: Congress may pull the plug on “Robot Bosses”
We’ve all heard the horror stories. A job seeker spends hours tailoring his resume, finally hits “submit,” and within seconds recei...
SEC Advances Capital Formation and Tokenization Initiatives as Congress Passes Venture Capital Bills and Prudential Regulators Address GENIUS Act Implementation and Debanking
The House passed two capital formation bills aimed at easing securities regulations for venture capital funds, and the following day SE...
From “Operation Chokepoint 2.0” to Fair Banking: What the House Report Alleges and How the OCC Responded
On November 25, the House Financial Services Committee majority staff published Operation Chokepoint 2.0: Biden’s Debanking of Digital ...
Sarepta Files Two IPRs Against Genzyme’s Patents Related to Gene Therapy Elevidys®
On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating t...